FLT3 and chronic myelogenous leukemia, BCR-ABL1 positive: Although SLAP displays an opposite expression level in AML and CML, the expression was significantly increased in APL patients carrying an Flt3-ITD mutation in comparison to patients carrying wild-type Flt3 (Fig. 7B).